A Pharmacoeconomic Analysis of Rimelolone for the Treatment of Ophthalmic Inflammatory ConditionsByMichael T. Halpern, MD, PhD,Cynthia S. Palmer, MSc,C. Stephen Foster, MD,Ashish Pal, BS Pharm, MBA,Carmelina Battista, PharmDJune 1st 1998
A Cost-Effectiveness Clinical Decision Analysis Model for SchizophreniaByCynthia S. Palmer, MSc,Dennis A. Revicki, PhD,Laura A. Genduso, PharmD,Susan H. Hamilton, MS,Ruth E. Brown, MSMarch 1st 1998
